Skip to content

Ketamine: all studies

Page 351 of 449: studies 3,501 to 3,510 of 4,483, newest first. Back to the ketamine overview

Research

Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist

The Journal of Clinical Psychiatry September 8, 2009 Rodrigo Machado‐Vieira, Peixiong Yuan, Nancy E. Brutsché et al. 154 citations

OBJECTIVE: A model has been proposed to explain the pathophysiology of mood disorders based on decreased neurotrophin levels during mood episodes; treatment with antidepressants and mood stabilizers is associated with clinical improvement. This study investigated whether changes in brain-derived neurotrophic factor (BDNF) levels are associated with the initial antidepressant effects of...

"Research chemicals": tryptamine and phenethylamine use among high-risk youth.

Substance Use & Misuse 2008 Bill Sanders, Stephen E Lankenau, Jennifer Jackson Bloom et al.

Tryptamines and phenethylamines are two broad categories of psychoactive substances with a long history of licit and illicit use. Profiles of users of recently emerging tryptamines and phenethylamines are nonexistent, however, since surveillance studies do not query the use of these substances. This manuscript describes the types, modes of administration, onset of use, and context of use of a...

5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users

European Addiction Research December 18, 2006 Jim Mccambridge, Adam Winstock, Neil Hunt et al. 113 citations

<i>Aims:</i> To describe and assess trends in the use of hallucinogens and other adjunct drugs over a 5-year period. <i>Design:</i> Repeated-measures cross-sectional survey. <i>Setting and Participants:</i> Annual magazine-based survey targeting people who use drugs in dance contexts. <i>Measurements:</i> Lifetime use prevalence (ever used); age of first use; current use prevalence (any use...

DOI: 10.1159/000095816 (opens in new tab) Psilocybin Ketamine Hallucinogen Psychological intervention +4

The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review

European Psychiatry December 1, 2000 F. Salomé, P Boyer, Michel Fayol 21 citations

The aim of this survey is to present an overview of research into psychopharmacology as regards the effects of different psychoactive drugs and neuroleptics (NL) on language in normal subjects and schizophrenic patients. Eighteen studies that have investigated the effects of different drugs (alcohol, amphetamines, secobarbital, L-dopa, psilocybin, ketamine, fenfluramine) and neuroleptics...

DOI: 10.1016/s0924-9338(00)00520-4 (opens in new tab) Ketamine Psilocybin Amphetamine Schizophrenia object-oriented programming +9

Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.

October 1, 1999 R. Andrew Chambers, J. Douglas Bremner, Bita Moghaddam et al. 140 citations

Dissociative cognitive and perceptual alterations commonly occur at the time of traumatization and as an enduring feature of post-traumatic stress disorder (PTSD). After stress exposure, dissociative symptoms are a predictor of the development of PTSD. Recent preclinical data suggest that stress stimulates the cortico-limbic release of glutamate. The glutamate that is released during stress in...

DOI: 10.153/scnp00400274 (opens in new tab) Ketamine Nmda receptor Glutamate receptor Dissociative +3

Neuroscience and the Near-Death Experience: Roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins

Medical Hypotheses 1990 Karl Jansen 96 citations

The Near-Death Experience (NDE) is a dissociative mental state with characteristic features. These can be reproduced by ketamine which acts at sigma sites and blocks N-methyl-D-aspartate (NMDA) linked phencyclidine (PCP) receptors to reduce ischaemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors which suggests an explanation for some NDE's: the...

DOI: 10.1016/0306-9877(90)90048-j (opens in new tab) Ketamine Phencyclidine Nmda receptor Sigma receptor +3

Angel Dust

JAMA August 8, 1977 Sidney Cohen 31 citations

PHENCYCLIDINE hydrochloride (Sernylan) was investigated during the 1950s as an anesthetic agent. Although it was found to be effective for analgesia and anesthesia, certain side effects, especially postoperative agitation and delirium that lasts for hours, precluded its final acceptance. Later, phencyclidine was discovered to be a satisfactory anesthetic agent for certain animals, and is...

DOI: 10.1001/jama.1977.03280060059027 (opens in new tab) Mescaline Phencyclidine Ketamine hydrochloride Anesthetic agent +2

JNDS, Volume 16, Number 1

University of North Texas Digital Library (University of North Texas) Bianchi

Abstract: Although ketamine can induce a state similar to a near-death experience (NDE), there is a striking difference between experiences induced by ketamine used in a recreational context and in an operating room. Ketamine is a noncompetitive antagonist of the N-methyl-D-aspartate receptor, as is ibogaine, the main alkaloid of a shrub used in Central Africa to induce NDEs in a religious...

Volumetric dilution nasal spray as a harm reduction strategy for intranasal psychoactive substance use: a practical framework and rationale

Harm Reduction Journal October 30, 2026 Alexandre Delforge

Abstract: Background: Intranasal insufflation of psychoactive substances, including cocaine, MDMA, and ketamine, is associated with a well-documented spectrum of nasal and sinonasal complications. These result from at least three distinct but interacting mechanisms: mechanical trauma from particulate matter, vasoconstriction-induced mucosal ischaemia (primarily relevant for cocaine), and...